Loading...
Vericel Corporation
VCEL•NASDAQ
Healthcare
Biotechnology
$41.45
$0.00(0.00%)
Vericel Corporation (VCEL) Financial Performance & Income Statement Overview
Review Vericel Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
20.10%
↑ 20.10%
Operating Income Growth
169.91%
↑ 169.91%
Net Income Growth
425.64%
↑ 425.64%
Operating Cash Flow Growth
64.72%
↑ 64.72%
Operating Margin
-1.18%
↓ 1.18%
Gross Margin
72.54%
↑ 72.54%
Net Profit Margin
1.25%
↑ 1.25%
ROE
1.09%
↑ 1.09%
ROIC
-0.73%
↓ 0.73%
Vericel Corporation (VCEL) Income Statement & Financial Overview
Review Vericel Corporation's (VCEL) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $52.60M | $75.38M | $57.91M | $52.66M |
| Cost of Revenue | $16.32M | $16.88M | $16.25M | $16.06M |
| Gross Profit | $36.27M | $58.50M | $41.65M | $36.60M |
| Gross Profit Ratio | $0.69 | $0.78 | $0.72 | $0.70 |
| R&D Expenses | $7.26M | $4.92M | $6.09M | $7.36M |
| SG&A Expenses | $41.80M | $35.10M | $38.02M | $35.27M |
| Operating Expenses | $49.06M | $40.02M | $44.12M | $42.63M |
| Total Costs & Expenses | $65.39M | $56.90M | $60.37M | $58.69M |
| Interest Income | $1.66M | $1.56M | $1.58M | $1.51M |
| Interest Expense | $153000.00 | $154000.00 | $154000.00 | $153000.00 |
| Depreciation & Amortization | $2.69M | $1.48M | $1.33M | $1.32M |
| EBITDA | -$8.41M | $21.59M | $579000.00 | -$3.21M |
| EBITDA Ratio | -$0.16 | $0.29 | $0.010 | -$0.06 |
| Operating Income | -$12.79M | $18.48M | -$2.46M | -$6.03M |
| Operating Income Ratio | -$0.24 | $0.25 | -$0.04 | -$0.11 |
| Other Income/Expenses (Net) | $1.55M | $1.48M | $1.56M | $1.35M |
| Income Before Tax | -$11.25M | $19.95M | -$901000.00 | -$4.68M |
| Income Before Tax Ratio | -$0.21 | $0.26 | -$0.02 | -$0.09 |
| Income Tax Expense | $0.00 | $148000.00 | $0.00 | $0.00 |
| Net Income | -$11.25M | $19.81M | -$901000.00 | -$4.68M |
| Net Income Ratio | -$0.21 | $0.26 | -$0.02 | -$0.09 |
| EPS | -$0.23 | $0.40 | -$0.02 | -$0.10 |
| Diluted EPS | -$0.23 | $0.38 | -$0.02 | -$0.10 |
| Weighted Avg Shares Outstanding | $49.91M | $49.47M | $49.09M | $48.69M |
| Weighted Avg Shares Outstanding (Diluted) | $49.91M | $52.21M | $49.09M | $48.69M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan